Internal Medicine, Medical Oncology · Ann Arbor, MI
NPI
1700962677
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1500 East Medical Center Dr, B1 Floor Cancer Ctr Recp C
Ann Arbor, MI, 48109
Phone (734) 647-8902
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
595 services
Medicare patients, 2024
120
Average age 73
Drug cost, 2024
$2.2M
898 prescriptions
Company payments, 2025
$31K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Francis P Worden was code G2212 (prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or), 291 times for 52 patients. In total Francis P Worden billed 595 services in 11 codes, and Medicare paid $29K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-04-04.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 291 | 52 | $24.80 | $7,217 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 96 | 62 | $13.12 | $1,260 |
| 99215 Office E&M - Established | Facility | 75 | 52 | $105.56 | $7,917 |
| 99214 Office E&M - Established | Facility | 70 | 47 | $75.39 | $5,277 |
| 99205 Office E&M - New | Facility | 38 | 38 | $143.81 | $5,465 |
By year: 2022 $26K for 261 services; 2023 $35K for 459 services; 2024 $29K for 595 services.
Medicare prescription drug claims, 2024
In 2024, the drug Francis P Worden prescribed most often to Medicare patients was Levothyroxine Sodium, with 131 prescriptions and refills. In total Francis P Worden wrote 898 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 131 | 330 | 47 | $1,646 |
| Prednisone Generic | 54 | 70 | 31 | $309 |
| Prochlorperazine Maleate Generic | 50 | 50 | 39 | $879 |
| Ondansetron Odt Ondansetron | 46 | 46 | 31 | $753 |
| Erivedge Vismodegib | 24 | 24 | Under 11 | $316K |
| Eliquis Apixaban | 24 | 40 | Under 11 | $24K |
| Lidocaine Hcl Viscous Lidocaine Hcl | 21 | 21 | Under 11 | $308 |
| Lenvima Lenvatinib Mesylate | 21 | 21 | Under 11 | $501K |
| Ondansetron Hcl Generic | 20 | 20 | 16 | $107 |
| Calcitriol Generic | 19 | 51 | Under 11 | $660 |
| Buprenorphine Generic | 19 | 19 | 14 | $3,204 |
| Synthroid Levothyroxine Sodium | 19 | 31 | Under 11 | $1,474 |
| Oxycodone Hcl Generic | 18 | 18 | 13 | $484 |
| Omeprazole Generic | 18 | 43 | Under 11 | $157 |
| Vitrakvi Larotrectinib Sulfate | 17 | 21 | Under 11 | $596K |
Brand drugs: - claims; generic drugs: 615 claims; opioid claims: 74.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Francis P Worden $31K ($30K in general payments such as food, travel and fees and $765 for research) from 7 companies. The largest payer was Sun Pharmaceutical Industries Inc. with $20K.
| Company | Payments | Amount |
|---|---|---|
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 20 | $20K |
| Eisai Inc. 4523.T | 4 | $6,577 |
| Merck Sharp & Dohme LLC MRK | 3 | $1,920 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $1,763 |
| Regeneron Pharmaceuticals, Inc. REGN | 2 | $765 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.